Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
0Q
0QZU.LSE
0Q
Vertex Pharmaceuticals Inc.
0QZU.LSE
News
·
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
Mkt Cap
N/A
Volume
172
Next Earnings
November 2nd
Chart
Financials
Earnings
News
About
Insider
Filings
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
Vertex Pharmaceuticals (VRTX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares of this drugmaker have returned -3.7% over the past month versu…
finance.yahoo.com · Apr 23, 2025
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among the rest: earnings. The earnings figure itself is key, but a beat or miss on the …
finance.yahoo.com · Apr 22, 2025
Vertex Pharmaceuticals (NasdaqGS:VRTX) Faces UK Patent Lawsuit Over Groundbreaking CASGEVY Therapy
Vertex Pharmaceuticals saw its share price rise by approximately 14% in the last quarter, a significant move considering the broader market's recent 1% decline. The company's legal challenges, such as the patent infringement lawsuit filed by ToolGen Inc., could have influenced in…
finance.yahoo.com · Apr 21, 2025
April 2025's Stocks That May Be Priced Below Their Estimated Value
As the U.S. stock market navigates a period of heightened volatility, with major indexes experiencing significant fluctuations amid tariff discussions and economic uncertainties, investors are keenly observing opportunities that may arise from these turbulent conditions. In such …
finance.yahoo.com · Apr 14, 2025
Exploring 3 High Growth Tech Stocks In The US Market
The United States market has experienced a notable uplift, climbing by 5.8% over the past week and showing a 4.8% increase over the last year, with earnings projected to grow by 14% annually in the coming years. In this environment, identifying high-growth tech stocks involves lo…
finance.yahoo.com · Apr 14, 2025
Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis
BOSTON, April 11, 2025--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Paul Negulescu, Ph.D. Senior Vice President, Vertex has been awarded the 2025 Canada Gairdner International Award "for pioneering research into the cellular and molecu…
finance.yahoo.com · Apr 11, 2025
Vertex Pharmaceuticals (VRTX) Stock Moves -1.41%: What You Should Know
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $475.49, marking a -1.41% move from the previous day. The stock outperformed the S&P 500, which registered a daily loss of 3.46%. At the same time, the Dow lost 2.5%, and the tech-heavy Nasdaq lost 4.31%. Comi…
finance.yahoo.com · Apr 10, 2025
Vertex Pharmaceuticals (VRTX) Surged on Increased Demand for its Cystic Fibrosis (CF) Franchise
GreensKeeper Asset Management, an investment management company, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here. Markets had a difficult start to 2025; with high levels of volatility in all of the main indices. The Value Fund finished…
finance.yahoo.com · Apr 10, 2025
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know
Vertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past month, shares of this drugmaker have returned -3.3%, compared t…
finance.yahoo.com · Apr 9, 2025
An Intrinsic Calculation For Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Suggests It's 41% Undervalued
Key Insights Vertex Pharmaceuticals' estimated fair value is US$797 based on 2 Stage Free Cash Flow to Equity Current share price of US$472 suggests Vertex Pharmaceuticals is potentially 41% undervalued The US$498 analyst price target for VRTX is 38% less than our estimate of fai…
finance.yahoo.com · Apr 9, 2025
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
0Q
0QZU.LSE
Vertex Pharmaceuticals Inc.
Buy
Sell
Market
Limit
Soon
0QZU.LSE
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any 0QZU.LSE yet.
Related Tickers
Earnings